Health Care Information and Resources

Court ruling could pave way for Gemzar generics

A decision by a U.S. appeals court could pave the way for cheaper generic drugs forms of Eli Lilly and Co’s Gemzar cancer drug to be launched in the United States beginning in mid-November. Many industry analysts have expected Gemzar to lose U.S. marketing exclusivity in mid-November, when protection on the blockbuster drug’s basic chemical [...]

Continue reading...